Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Maria C. Z. Meneghetti,et al. Heparan sulfate and heparin interactions with proteins. J R Soc Interface. 2015 Sep 6; 12(110): 20150589. doi: 10.1098/rsif.2015.0589.
[2] Lori-Ann Linkins,et al. Treatment and Prevention of Heparin-Induced Thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl): e495S–e530S. Published online 2012 Jan 23. doi: 10.1378/chest.11-2303. Correction in: Chest. 2015 Dec; 148(6): 1529.
[3] Meital Cohen-Mazor,et al. Heparin Interaction with the Primed Polymorphonuclear Leukocyte CD11b Induces Apoptosis and Prevents Cell Activation. J Immunol Res. 2015; 2015: 751014. Published online 2015 Dec 27. doi: 10.1155/2015/751014.
分子式 C26H42N2O37S5 |
分子量 1134.93 |
CAS号 9005-49-6 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO <1 mg/mL |
Water 10 mM |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT01598883 | Cardiopulmonary Bypass|Altered Heparin Response | Drug: Heparin|Drug: ATryn | Massachusetts General Hospital|rEVO Biologics | Phase 1 | 2012-06-01 | 2016-12-13 |
NCT01092455 | Renal Dialysis | Drug: Heparin N reduction | Randolph Quinn|Fresenius Medical Care North America | Phase 4 | 2009-12-01 | 2011-08-31 |
NCT00701623 | Burns | Drug: heparin|Drug: heparin|Drug: folder water | Azidus Brasil | Phase 2|Phase 3 | 2008-06-01 | 2010-10-26 |
NCT01229072 | Chronic Renal Failure | Biological: Heparin sodic|Biological: heparin liquemine | Azidus Brasil | Phase 2|Phase 3 | 2008-07-01 | 2010-10-26 |
NCT01454869 | Heparin | Drug: standard care|Drug: Heparin | Tehran University of Medical Sciences | Phase 3 | 2012-02-01 | 2012-12-14 |
NCT00848796 | Coronary Artery Bypass Grafting | Drug: Heparin Leo and Hepalean | Southlake Regional Health Centre | 2006-09-01 | 2009-02-19 | |
NCT01260519 | Diagnostic Coronary Angiography | Drug: Heparin | Prince Sultan Cardiac Center, Adult Cardiology Department. | Phase 3 | 2008-07-01 | 2010-12-14 |
NCT01694459 | Stable Angina|Angina, Unstable|Non-ST Elevation (NSTEMI) Myocardial Infarction | Drug: Low-dose heparin|Drug: Standard dose heparin | San Filippo Neri General Hospital|University of Roma La Sapienza | Phase 4 | 2010-01-01 | 2012-09-26 |
NCT00894673 | Cardiac Surgery | Biological: Heparin sodium Hipolabor|Biological: Heparin sodium APP | Azidus Brasil | Phase 3 | 2009-07-01 | 2013-02-22 |
NCT01318811 | Acute Kidney Injury|Acute Renal Failure|Heart Failure | Drug: Dilute unfractionated heparin|Drug: Standard concentration unfractionated heparin | Vanderbilt University | Phase 4 | 2011-03-01 | 2016-05-06 |
NCT01363193 | Obesity|Morbid Obesity|Venous Thromboembolism|Atrial Fibrillation|Angina|Chest Pain | Drug: Lean Body Weight-based heparin dose | Nazareth Hospital | 2011-07-01 | 2013-05-13 | |
NCT02144064 | Recurrent Miscarriage | Drug: Heparin | Benha University | Phase 3 | 2012-06-01 | 2015-03-06 |
NCT00587444 | Postoperative Hemorrhage | Drug: Heparin|Drug: HH or high heparin|Drug: heparin concentration HC | Mayo Clinic|Medtronic | Phase 3 | 2001-06-01 | 2009-10-14 |
NCT02707263 | Venous Thromboembolism | Drug: intravenous continuous infusion of heparin (IV UFH)|Drug: Subcutaneous Heparin | New York University School of Medicine | 2016-03-01 | 2016-10-06 | |
NCT01388270 | Renal Failure | Device: a pre-heparin-coated hemodialysis filter; Hepran | Oslo University Hospital | Phase 4 | 2011-09-01 | 2016-02-03 |
NCT02493504 | Arteriovenous Fistula | Drug: Heparin | Fatemeh Hoseinzadegan|Shahid Beheshti University of Medical Sciences | Phase 4 | 2011-01-01 | 2015-07-07 |
NCT01823393 | Aortic Stenosis, Non-rheumatic | Drug: Heparin|Drug: NaCl | University Hospital, Montpellier | Phase 4 | 2013-01-01 | 2016-11-30 |
NCT00828776 | Chronic Renal Failure | Biological: Heparin sodic - Cristlia|Biological: heparin - Liquemine (Roche) | Azidus Brasil | Phase 2|Phase 3 | 2007-09-01 | 2009-01-23 |
NCT02654561 | Sepsis|Disseminated Intravascular Coagulation | Drug: Heparin Sodium|Drug: Saline | China Medical University, China|Peking Union Medical College Hospital|West China Hospital|First Affiliated Hospital, Sun Yat-Sen University|Central South University|The Second Affiliated Hospital of Harbin Medical University|Zhongda Hospital|Zhejiang Hospital|The First Affiliated Hospital of Dalian Medical University|Shengjing Hospital | Phase 3 | 2016-05-01 | 2016-01-12 |
NCT00894829 | Cardiac Surgery | Biological: heparin sodium - Eurofarma|Biological: heparin sodium - APP | Azidus Brasil | Phase 3 | 2009-06-01 | 2013-02-22 |
NCT02501434 | Aneurysmal Subarachnoid Hemorrhage|Neurobehavioral Manifestations|Vasospasm, Intracranial|Intracranial Aneurysm|Heparin-induced Thrombocytopenia Type II | Drug: Continuous Low-Dose Intravenous Unfractionated Heparin Infusion (14 days) | Robert F James, MD, FACS, FAANS|University of Louisville | Phase 2 | 2016-03-01 | 2016-04-15 |
NCT00894998 | Cardiac Surgery | Biological: heparin sodium - Cristlia|Biological: Heparin sodium APP | Azidus Brasil | Phase 3 | 2009-06-01 | 2013-02-22 |
NCT00894985 | Cardiac Surgery | Biological: heparin sodium - blausiegel|Biological: heparin sodium - APP | Azidus Brasil | Phase 3 | 2009-06-01 | 2013-02-22 |
NCT01072747 | Prevention of Venous Thromboembolism | Biological: bovine heparin|Biological: Porcine heparin | Azidus Brasil | Phase 3 | 2010-04-01 | 2011-01-27 |
NCT00894959 | Cardiac Surgery | Biological: Heparin sodium Blausiegel 1|Biological: Heparin sodium APP | Azidus Brasil | Phase 3 | 2009-07-01 | 2013-02-22 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们